SIBELIUM

This brand name is authorized in Austria, France, Ireland, Malta, Mexico, Netherlands, Romania, South Africa, Spain, Turkey.

Active ingredients

The drug SIBELIUM contains one active pharmaceutical ingredient (API):

1	Flunarizine UNII C11102TO53 - FLUNARIZINE HYDROCHLORIDE
	Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
	Read more about Flunarizine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SIBELIUM Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07CA03	Flunarizine	N Nervous system → N07 Other nervous system drugs → N07C Antivertigo preparations → N07CA Antivertigo preparations
Discover more medicines within N07CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	55352
FR	Base de données publique des médicaments	61247136
IE	Health Products Regulatory Authority	45988
MT	Medicines Authority	AA1228/01601
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	444M96
NL	Z-Index G-Standaard, PRK	29890
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66819001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699593015274, 8699593015281
ZA	Health Products Regulatory Authority	43/5.7.1/0451, M/5.7.1/530